{"id":238772,"date":"2026-09-09T16:07:24","date_gmt":"2026-09-09T10:37:24","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/"},"modified":"2026-10-19T16:07:32","modified_gmt":"2026-10-19T10:37:32","slug":"nifty-pharma-today-market-wrap-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/","title":{"rendered":"Nifty Pharma Today: Close, Stocks, Breadth and Performance"},"content":{"rendered":"<p><a href=\"https:\/\/univest.in\/screeners\/nifty-pharma\">Nifty Pharma<\/a> today closed in the red, reflecting a weak session across most pharmaceutical stocks in the index. The index ended at 25,615, down 166.65 points or 0.65%, as declines in a large majority of constituents outweighed gains in only a few names. For investors tracking sector performance, this was a session defined by broad-based selling pressure rather than a fall caused by just one or two stocks.<\/p>\n<p>The day\u2019s pattern also matters. Nifty Pharma opened at 25,769.3, moved up to an intraday high of 26,020.45, and then slipped to a low of 25,565.4 before settling near the lower end of the day\u2019s range. That intraday reversal suggests that early strength did not sustain and sellers retained control into the close.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#Nifty_Pharma_Index_Snapshot\" title=\"Nifty Pharma Index Snapshot\">Nifty Pharma Index Snapshot<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#Quick_Summary\" title=\"Quick Summary\">Quick Summary<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#Why_Nifty_Pharma_Moved_Today\" title=\"Why Nifty Pharma Moved Today\">Why Nifty Pharma Moved Today<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#Market_Breadth\" title=\"Market Breadth\">Market Breadth<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#Complete_Constituent_Performance\" title=\"Complete Constituent Performance\">Complete Constituent Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#Top_Stocks_Supporting_the_Index\" title=\"Top Stocks Supporting the Index\">Top Stocks Supporting the Index<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#Top_Draggers_on_Nifty_Pharma\" title=\"Top Draggers on Nifty Pharma\">Top Draggers on Nifty Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#How_Nifty_Pharma_Performed_Versus_Other_Market_Indices\" title=\"How Nifty Pharma Performed Versus Other Market Indices\">How Nifty Pharma Performed Versus Other Market Indices<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#Price_Structure_and_Session_Analysis\" title=\"Price Structure and Session Analysis\">Price Structure and Session Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#Stock_Activity_and_Participation\" title=\"Stock Activity and Participation\">Stock Activity and Participation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#Short-Term_and_Longer-Period_Stock_Performance\" title=\"Short-Term and Longer-Period Stock Performance\">Short-Term and Longer-Period Stock Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#What_Investors_Should_Watch_Next\" title=\"What Investors Should Watch Next\">What Investors Should Watch Next<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#Key_Takeaways\" title=\"Key Takeaways\">Key Takeaways<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#Know_more_with_Univest\" title=\"Know more with Univest\">Know more with Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#1_How_did_Nifty_Pharma_close_today\" title=\"1. How did Nifty Pharma close today?\">1. How did Nifty Pharma close today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#2_Why_did_Nifty_Pharma_fall_today\" title=\"2. Why did Nifty Pharma fall today?\">2. Why did Nifty Pharma fall today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#3_Which_stock_gained_the_most_in_Nifty_Pharma_today\" title=\"3. Which stock gained the most in Nifty Pharma today?\">3. Which stock gained the most in Nifty Pharma today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#4_Which_stock_fell_the_most_in_Nifty_Pharma_today\" title=\"4. Which stock fell the most in Nifty Pharma today?\">4. Which stock fell the most in Nifty Pharma today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#5_How_was_the_market_breadth_of_Nifty_Pharma_today\" title=\"5. How was the market breadth of Nifty Pharma today?\">5. How was the market breadth of Nifty Pharma today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#6_What_does_the_advance-decline_ratio_of_019_mean_for_Nifty_Pharma\" title=\"6. What does the advance-decline ratio of 0.19 mean for Nifty Pharma?\">6. What does the advance-decline ratio of 0.19 mean for Nifty Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#7_How_did_Nifty_Pharma_compare_with_other_sector_indices_today\" title=\"7. How did Nifty Pharma compare with other sector indices today?\">7. How did Nifty Pharma compare with other sector indices today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#8_Which_Nifty_Pharma_stocks_were_most_actively_traded_today\" title=\"8. Which Nifty Pharma stocks were most actively traded today?\">8. Which Nifty Pharma stocks were most actively traded today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#9_What_does_Nifty_Pharma_track\" title=\"9. What does Nifty Pharma track?\">9. What does Nifty Pharma track?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#10_How_many_stocks_are_in_Nifty_Pharma_and_what_should_investors_watch_next\" title=\"10. How many stocks are in Nifty Pharma, and what should investors watch next?\">10. How many stocks are in Nifty Pharma, and what should investors watch next?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/nifty-pharma-today-market-wrap-2026\/#Disclaimer\" title=\"Disclaimer\">Disclaimer<\/a><\/li><\/ul><\/nav><\/div>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Nifty_Pharma_Index_Snapshot\"><\/span>Nifty Pharma Index Snapshot<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tr>\n<th>Metric<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>Current Value<\/td>\n<td>25,615<\/td>\n<\/tr>\n<tr>\n<td>Absolute Change<\/td>\n<td>-166.65<\/td>\n<\/tr>\n<tr>\n<td>Percentage Change<\/td>\n<td>-0.65%<\/td>\n<\/tr>\n<tr>\n<td>Opening Value<\/td>\n<td>25,769.3<\/td>\n<\/tr>\n<tr>\n<td>Previous Close<\/td>\n<td>25,781.65<\/td>\n<\/tr>\n<tr>\n<td>Day High<\/td>\n<td>26,020.45<\/td>\n<\/tr>\n<tr>\n<td>Day Low<\/td>\n<td>25,565.4<\/td>\n<\/tr>\n<tr>\n<td>Market Status<\/td>\n<td>Closed<\/td>\n<\/tr>\n<tr>\n<td>Last Updated<\/td>\n<td>19 October 2026 at 4:00:00 PM IST<\/td>\n<\/tr>\n<tr>\n<td>Market Trend<\/td>\n<td>Bearish<\/td>\n<\/tr>\n<\/table>\n<p>Nifty Pharma finished below both its opening level and previous close, which confirms that the session weakened as the day progressed. The index briefly traded above the prior close early in the day, but the inability to hold that strength was a key signal. Because the close came very close to the day\u2019s low, the final print indicates continued selling pressure into the end of the session.<\/p>\n<p>In plain language, pharma stocks as a group had a negative day. While a handful of stocks still managed gains, they were not enough to offset declines across the rest of the basket. When an index falls and closes near the lower end of its intraday range, it usually means sellers had the upper hand for most of the latter part of the trading session.<\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Quick_Summary\"><\/span>Quick Summary<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Nifty Pharma closed at 25,615, down 0.65%, after giving up early gains and sliding toward the day\u2019s low by the close. The move was driven less by one isolated event and more by widespread weakness across constituents, with 16 declining stocks against only 3 advancing stocks. Natco Pharma, Dr. Reddy&#8217;s Laboratories, and Laurus Labs were the main positive movers, while JB Chemicals &amp; Pharmaceuticals, Aurobindo Pharma, and Biocon were among the biggest drags. Investors should now watch whether breadth improves in the next session and whether recent underperformers continue to pressure the index.<\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Why_Nifty_Pharma_Moved_Today\"><\/span>Why Nifty Pharma Moved Today<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The clearest explanation for today\u2019s Nifty Pharma decline is the breadth of the fall. Out of 20 constituents, 16 closed lower and only 3 ended in the green, while 1 stock was unchanged. That kind of distribution usually points to broad selling across the sector rather than stock-specific pressure in only a narrow pocket of the index.<\/p>\n<p>The intraday path supports the same reading. Nifty Pharma opened only slightly below the previous close, rose to 26,020.45, and then reversed lower. A session that starts relatively stable, tests higher levels, and then closes near the low often suggests that buying interest was not strong enough to absorb later supply. In market terms, early optimism faded and sellers dominated into the close.<\/p>\n<p>The constituent list also shows that the declines were spread across multiple pharma names. Stocks such as JB Chemicals &amp; Pharmaceuticals, Aurobindo Pharma, Biocon, Granules India, Lupin, Abbott India, Ipca Laboratories, Mankind Pharma, Alkem Laboratories, and Sun Pharmaceutical Industries all closed lower. When weakness is this widely distributed, the sector index typically struggles to recover even if a few stocks post gains.<\/p>\n<p>On the positive side, Natco Pharma rose 2.01%, Dr. Reddy&#8217;s Laboratories gained 0.77%, and Laurus Labs added 0.43%. Those advances show that there was some selective buying within the sector. However, the positive moves were too limited in number to change the overall tone of the day.<\/p>\n<p>So the most reliable explanation for today\u2019s move is simple: Nifty Pharma fell because the majority of its constituents declined, and the index lost momentum after failing to hold its early high. That combination of weak breadth and an intraday reversal created a bearish close.<\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Market_Breadth\"><\/span>Market Breadth<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tr>\n<th>Breadth Metric<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>Advancing Stocks<\/td>\n<td>3<\/td>\n<\/tr>\n<tr>\n<td>Declining Stocks<\/td>\n<td>16<\/td>\n<\/tr>\n<tr>\n<td>Unchanged Stocks<\/td>\n<td>1<\/td>\n<\/tr>\n<tr>\n<td>Advance-Decline Ratio<\/td>\n<td>0.19<\/td>\n<\/tr>\n<tr>\n<td>Stocks in Green<\/td>\n<td>15%<\/td>\n<\/tr>\n<tr>\n<td>Stocks in Red<\/td>\n<td>80%<\/td>\n<\/tr>\n<\/table>\n<p>Market breadth was decisively negative. Only 15% of the index constituents finished in the green, while 80% closed in the red. The advance-decline ratio of 0.19 means that for roughly every one advancing stock, there were more than five declining stocks.<\/p>\n<p>This matters because breadth often tells a deeper story than the headline index move. An index can sometimes fall because a few large components drag it lower, even when many smaller constituents rise. That was not the case here. Today\u2019s breadth indicates widespread weakness, which usually points to a more convincing bearish session at the sector level.<\/p>\n<p>For short-term observers, this breadth profile suggests caution. A weak breadth reading means the selling pressure was not isolated. For medium-term watchers, the next important question is whether this poor breadth was a one-day event or the start of a broader stretch of underperformance within the pharma pack.<\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Complete_Constituent_Performance\"><\/span>Complete Constituent Performance<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tr>\n<th>Company<\/th>\n<th>CMP<\/th>\n<th>Today&#8217;s %<\/th>\n<th>Today&#8217;s Change<\/th>\n<th>Volume<\/th>\n<th>Trend<\/th>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/jbchepharm\/jb-chemicals-and-pharmaceuticals-ltd-share-price-today\">JB Chemicals &amp; Pharmaceuticals Ltd.<\/a><\/td>\n<td>2,408.9<\/td>\n<td>-3.87%<\/td>\n<td>-97.1<\/td>\n<td>4,779,224<\/td>\n<td>Bearish<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/auropharma\/aurobindo-pharma-ltd-share-price-today\">Aurobindo Pharma Ltd.<\/a><\/td>\n<td>1,621.4<\/td>\n<td>-2.73%<\/td>\n<td>-45.5<\/td>\n<td>736,433<\/td>\n<td>Bearish<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/biocon\/biocon-ltd-share-price-today\">Biocon Ltd.<\/a><\/td>\n<td>340<\/td>\n<td>-2.63%<\/td>\n<td>-9.2<\/td>\n<td>3,222,416<\/td>\n<td>Bearish<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/granules\/granules-india-ltd-share-price-today\">Granules India Ltd.<\/a><\/td>\n<td>806.05<\/td>\n<td>-2.34%<\/td>\n<td>-19.3<\/td>\n<td>874,275<\/td>\n<td>Bearish<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/natcopharm\/natco-pharma-ltd-share-price-today\">Natco Pharma Ltd.<\/a><\/td>\n<td>800.85<\/td>\n<td>2.01%<\/td>\n<td>15.8<\/td>\n<td>768,065<\/td>\n<td>Bullish<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/lupin\/lupin-ltd-share-price-today\">Lupin Ltd.<\/a><\/td>\n<td>1,939.2<\/td>\n<td>-1.14%<\/td>\n<td>-22.4<\/td>\n<td>602,008<\/td>\n<td>Bearish<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/abbotindia\/abbott-india-ltd-share-price-today\">Abbott India Ltd.<\/a><\/td>\n<td>25,905<\/td>\n<td>-1.01%<\/td>\n<td>-265<\/td>\n<td>2,009<\/td>\n<td>Bearish<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/ipcalab\/ipca-laboratories-ltd-share-price-today\">Ipca Laboratories Ltd.<\/a><\/td>\n<td>1,814.5<\/td>\n<td>-0.99%<\/td>\n<td>-18.1<\/td>\n<td>167,626<\/td>\n<td>Bearish<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/mankind\/mankind-pharma-ltd-share-price-today\">Mankind Pharma Ltd.<\/a><\/td>\n<td>2,253.2<\/td>\n<td>-0.98%<\/td>\n<td>-22.3<\/td>\n<td>1,228,705<\/td>\n<td>Bearish<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/alkem\/alkem-laboratories-ltd-share-price-today\">Alkem Laboratories Ltd.<\/a><\/td>\n<td>5,004<\/td>\n<td>-0.91%<\/td>\n<td>-46<\/td>\n<td>95,218<\/td>\n<td>Bearish<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\">Sun Pharmaceutical Industries Ltd.<\/a><\/td>\n<td>1,743<\/td>\n<td>-0.9%<\/td>\n<td>-15.8<\/td>\n<td>829,445<\/td>\n<td>Bearish<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/ajantpharm\/ajanta-pharma-ltd-share-price-today\">Ajanta Pharma Ltd.<\/a><\/td>\n<td>3,298.9<\/td>\n<td>-0.9%<\/td>\n<td>-30.1<\/td>\n<td>36,644<\/td>\n<td>Bearish<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\">Zydus Lifesciences Ltd.<\/a><\/td>\n<td>1,113.9<\/td>\n<td>-0.81%<\/td>\n<td>-9.1<\/td>\n<td>253,448<\/td>\n<td>Bearish<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/gland\/gland-pharma-ltd-share-price-today\">Gland Pharma Ltd.<\/a><\/td>\n<td>3,019.8<\/td>\n<td>-0.78%<\/td>\n<td>-23.6<\/td>\n<td>167,122<\/td>\n<td>Bearish<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/drreddy\/dr-reddy's-laboratories-ltd-share-price-today\">Dr. Reddy&#8217;s Laboratories Ltd.<\/a><\/td>\n<td>1,242.5<\/td>\n<td>0.77%<\/td>\n<td>9.5<\/td>\n<td>1,023,837<\/td>\n<td>Bullish<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/glenmark\/glenmark-pharmaceuticals-ltd-share-price-today\">Glenmark Pharmaceuticals Ltd.<\/a><\/td>\n<td>2,210.2<\/td>\n<td>-0.74%<\/td>\n<td>-16.5<\/td>\n<td>285,702<\/td>\n<td>Bearish<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi's-laboratories-ltd-share-price-today\">Divi&#8217;s Laboratories Ltd.<\/a><\/td>\n<td>9,087<\/td>\n<td>-0.63%<\/td>\n<td>-57.5<\/td>\n<td>448,972<\/td>\n<td>Bearish<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/lauruslabs\/laurus-labs-ltd-share-price-today\">Laurus Labs Ltd.<\/a><\/td>\n<td>2,069<\/td>\n<td>0.43%<\/td>\n<td>8.9<\/td>\n<td>1,133,053<\/td>\n<td>Bullish<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\">Cipla Ltd.<\/a><\/td>\n<td>1,324.1<\/td>\n<td>-0.08%<\/td>\n<td>-1<\/td>\n<td>1,387,215<\/td>\n<td>Bearish<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\">Torrent Pharmaceuticals Ltd.<\/a><\/td>\n<td>4,558.7<\/td>\n<td>0%<\/td>\n<td>-0.2<\/td>\n<td>250,305<\/td>\n<td>Sideways<\/td>\n<\/tr>\n<\/table>\n<p>The best performer in the index was Natco Pharma, which rose 2.01%. The worst performer was JB Chemicals &amp; Pharmaceuticals, which fell 3.87%. Those two stocks framed the outer edge of today\u2019s sector move.<\/p>\n<p>The broader table shows how widespread the weakness was. Several stocks declined by close to or more than 1%, and only three names managed gains. When losses are distributed across diversified pharma businesses rather than concentrated in one corner of the sector, the index tends to reflect a more durable negative tone for that session.<\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Top_Stocks_Supporting_the_Index\"><\/span>Top Stocks Supporting the Index<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tr>\n<th>Company<\/th>\n<th>Price Change<\/th>\n<th>% Move<\/th>\n<th>Reason Behind Move<\/th>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/natcopharm\/natco-pharma-ltd-share-price-today\">Natco Pharma Ltd.<\/a><\/td>\n<td>15.8<\/td>\n<td>2.01%<\/td>\n<td>Among the few constituents to attract buying interest and finish firmly in the green.<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/drreddy\/dr-reddy's-laboratories-ltd-share-price-today\">Dr. Reddy&#8217;s Laboratories Ltd.<\/a><\/td>\n<td>9.5<\/td>\n<td>0.77%<\/td>\n<td>Held gains through the session and helped offset part of the broader sector weakness.<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/lauruslabs\/laurus-labs-ltd-share-price-today\">Laurus Labs Ltd.<\/a><\/td>\n<td>8.9<\/td>\n<td>0.43%<\/td>\n<td>Closed higher in a weak market, showing relative resilience versus most peers.<\/td>\n<\/tr>\n<\/table>\n<p>These three gainers were important because they prevented the sector from falling more sharply. Natco Pharma led the advances by a comfortable margin, while Dr. Reddy&#8217;s Laboratories and Laurus Labs added modest support. Still, with only three gainers in the entire index, their contribution was defensive rather than trend-changing.<\/p>\n<p>Another useful observation is that the positive side was narrow. A healthy uptrend usually needs broad participation. Today\u2019s gainers list was short, which means the buying was selective and not strong enough to lift the overall pharma basket.<\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Top_Draggers_on_Nifty_Pharma\"><\/span>Top Draggers on Nifty Pharma<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tr>\n<th>Company<\/th>\n<th>Price Change<\/th>\n<th>% Move<\/th>\n<th>Reason Behind Fall<\/th>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/jbchepharm\/jb-chemicals-and-pharmaceuticals-ltd-share-price-today\">JB Chemicals &amp; Pharmaceuticals Ltd.<\/a><\/td>\n<td>-97.1<\/td>\n<td>-3.87%<\/td>\n<td>Sharp selling pressure made it the weakest stock in the index for the day.<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/auropharma\/aurobindo-pharma-ltd-share-price-today\">Aurobindo Pharma Ltd.<\/a><\/td>\n<td>-45.5<\/td>\n<td>-2.73%<\/td>\n<td>One of the largest percentage declines in the basket, adding to sector weakness.<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/biocon\/biocon-ltd-share-price-today\">Biocon Ltd.<\/a><\/td>\n<td>-9.2<\/td>\n<td>-2.63%<\/td>\n<td>Extended the negative breadth by closing among the steepest decliners.<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/granules\/granules-india-ltd-share-price-today\">Granules India Ltd.<\/a><\/td>\n<td>-19.3<\/td>\n<td>-2.34%<\/td>\n<td>Meaningful decline that reinforced the downbeat tone across pharma shares.<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/lupin\/lupin-ltd-share-price-today\">Lupin Ltd.<\/a><\/td>\n<td>-22.4<\/td>\n<td>-1.14%<\/td>\n<td>Closed lower and added to the cumulative drag from multiple mid-to-large constituents.<\/td>\n<\/tr>\n<\/table>\n<p>JB Chemicals &amp; Pharmaceuticals stood out clearly as the biggest drag of the day after falling 3.87%. Aurobindo Pharma and Biocon also posted significant losses, while Granules India and Lupin added to the downside pressure. These declines did not occur in isolation; they came alongside losses in many other constituents, which amplified the index impact.<\/p>\n<p>This is an important distinction for investors. A sector index can often shrug off one weak stock, but it becomes far harder to do so when several prominent names decline together. That was the pattern today, and it explains why the Nifty Pharma close stayed weak.<\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"How_Nifty_Pharma_Performed_Versus_Other_Market_Indices\"><\/span>How Nifty Pharma Performed Versus Other Market Indices<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tr>\n<th>Index<\/th>\n<th>Close<\/th>\n<th>Change<\/th>\n<th>Change %<\/th>\n<th>Relative View vs Nifty Pharma<\/th>\n<\/tr>\n<tr>\n<td>Nifty IT<\/td>\n<td>31,516.3<\/td>\n<td>-407.8<\/td>\n<td>-1.28%<\/td>\n<td>Nifty Pharma outperformed<\/td>\n<\/tr>\n<tr>\n<td>Nifty Metal<\/td>\n<td>12,066.4<\/td>\n<td>-66.8<\/td>\n<td>-0.55%<\/td>\n<td>Nifty Pharma underperformed<\/td>\n<\/tr>\n<tr>\n<td>Nifty Bank<\/td>\n<td>55,488.1<\/td>\n<td>-355.9<\/td>\n<td>-0.64%<\/td>\n<td>Nearly in line; Nifty Pharma slightly underperformed<\/td>\n<\/tr>\n<tr>\n<td>Nifty Financial Services<\/td>\n<td>24,987.1<\/td>\n<td>-400<\/td>\n<td>-1.58%<\/td>\n<td>Nifty Pharma outperformed<\/td>\n<\/tr>\n<tr>\n<td>Nifty Auto<\/td>\n<td>25,591.25<\/td>\n<td>-177.25<\/td>\n<td>-0.69%<\/td>\n<td>Nifty Pharma outperformed slightly<\/td>\n<\/tr>\n<tr>\n<td>Nifty FMCG<\/td>\n<td>43,975.5<\/td>\n<td>-640.65<\/td>\n<td>-1.44%<\/td>\n<td>Nifty Pharma outperformed<\/td>\n<\/tr>\n<tr>\n<td>Nifty Pharma<\/td>\n<td>25,615<\/td>\n<td>-166.65<\/td>\n<td>-0.65%<\/td>\n<td>\u2014<\/td>\n<\/tr>\n<tr>\n<td>Nifty Mid Select<\/td>\n<td>13,565.15<\/td>\n<td>-152.25<\/td>\n<td>-1.11%<\/td>\n<td>Nifty Pharma outperformed<\/td>\n<\/tr>\n<\/table>\n<p>Nifty Pharma was weak, but not the weakest part of the market. It performed better than Nifty IT, Nifty Financial Services, Nifty FMCG, and Nifty Mid Select. It was roughly in line with Nifty Bank and slightly better than Nifty Auto. Only Nifty Metal held up better among the listed indices.<\/p>\n<p>This comparison adds useful context. The pharma index had a negative day, but the broader market tone across several sectors was also soft. That means the decline in Nifty Pharma was part of a wider risk-off session across many pockets of the market, even though its own breadth remained especially poor.<\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Price_Structure_and_Session_Analysis\"><\/span>Price Structure and Session Analysis<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>At the index level, the most notable technical feature of the day was the intraday reversal. Nifty Pharma moved above its previous close and touched 26,020.45, but then sold off and finished at 25,615. The close near the day\u2019s low of 25,565.4 indicates that sellers remained in control into the final phase of the session.<\/p>\n<p>That type of structure is generally considered short-term bearish because it shows rejection at higher levels. In simple terms, buyers pushed the index up early, but they were unable to sustain those levels. Sellers then regained control and drove the index back down.<\/p>\n<p>The day\u2019s range was 455.05 points, calculated from the high of 26,020.45 and low of 25,565.4. Closing close to the bottom of such a range usually reflects weak sentiment at the end of trade. If a market closes near its high, that often signals strength carrying into the next session. The reverse happened here.<\/p>\n<p>Within the constituents, the same structure appeared in several names. A number of stocks opened near or at the previous close and still ended lower, which suggests fading intraday conviction. The combination of weak breadth, an index close near the session low, and only three advancing stocks points to a negative short-term tone for the sector.<\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Stock_Activity_and_Participation\"><\/span>Stock Activity and Participation<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Trading activity helps show where attention was concentrated inside the index. Among the actively traded names, JB Chemicals &amp; Pharmaceuticals recorded volume of 4,779,224 shares with turnover of 1,151.27 crore, making it one of the session\u2019s standout counters in terms of participation. Its steep 3.87% fall also meant that high activity came alongside clear selling pressure.<\/p>\n<p>Other actively traded stocks included Cipla with volume of 1,387,215 shares, Mankind Pharma with 1,228,705 shares, Laurus Labs with 1,133,053 shares, and Dr. Reddy&#8217;s Laboratories with 1,023,837 shares. This mix is interesting because it included both gainers and losers, showing that investor activity was elevated across the sector rather than limited to one direction.<\/p>\n<p>Divi&#8217;s Laboratories also drew attention with turnover of 407.98 crore, despite a relatively moderate fall of 0.63%. High turnover paired with a contained decline can sometimes indicate active two-way trade rather than one-sided panic. In contrast, JB Chemicals &amp; Pharmaceuticals combined very high turnover with the sharpest price fall, which marked it as the day\u2019s most pressured stock.<\/p>\n<p>Activity metrics do not tell investors why a stock moved, but they do show where market participation was concentrated. Today, the high-volume and high-turnover list reinforces the broader message of the session: Nifty Pharma weakness was supported by active trading, not by a thin or inactive market.<\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Short-Term_and_Longer-Period_Stock_Performance\"><\/span>Short-Term and Longer-Period Stock Performance<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tr>\n<th>Company<\/th>\n<th>1 Month<\/th>\n<th>3 Months<\/th>\n<th>6 Months<\/th>\n<th>1 Year<\/th>\n<th>5 Years<\/th>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/auropharma\/aurobindo-pharma-ltd-share-price-today\">Aurobindo Pharma Ltd.<\/a><\/td>\n<td>-5.37%<\/td>\n<td>3.96%<\/td>\n<td>18.54%<\/td>\n<td>47.48%<\/td>\n<td>127.55%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/biocon\/biocon-ltd-share-price-today\">Biocon Ltd.<\/a><\/td>\n<td>-13.92%<\/td>\n<td>-22.11%<\/td>\n<td>-5.31%<\/td>\n<td>-6.67%<\/td>\n<td>-1.28%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/granules\/granules-india-ltd-share-price-today\">Granules India Ltd.<\/a><\/td>\n<td>-7.9%<\/td>\n<td>-8%<\/td>\n<td>21.31%<\/td>\n<td>42.46%<\/td>\n<td>152.09%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/natcopharm\/natco-pharma-ltd-share-price-today\">Natco Pharma Ltd.<\/a><\/td>\n<td>-1.89%<\/td>\n<td>-15.76%<\/td>\n<td>-27.2%<\/td>\n<td>-3.93%<\/td>\n<td>-9.21%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/lupin\/lupin-ltd-share-price-today\">Lupin Ltd.<\/a><\/td>\n<td>-8.72%<\/td>\n<td>-21.76%<\/td>\n<td>-16.73%<\/td>\n<td>-0.24%<\/td>\n<td>106.65%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/abbotindia\/abbott-india-ltd-share-price-today\">Abbott India Ltd.<\/a><\/td>\n<td>-3.91%<\/td>\n<td>-6.24%<\/td>\n<td>3.77%<\/td>\n<td>-11.42%<\/td>\n<td>28.85%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/ipcalab\/ipca-laboratories-ltd-share-price-today\">Ipca Laboratories Ltd.<\/a><\/td>\n<td>-9.65%<\/td>\n<td>-1.31%<\/td>\n<td>23.55%<\/td>\n<td>42.76%<\/td>\n<td>54.95%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/mankind\/mankind-pharma-ltd-share-price-today\">Mankind Pharma Ltd.<\/a><\/td>\n<td>-7.57%<\/td>\n<td>-12.18%<\/td>\n<td>5.09%<\/td>\n<td>-8.22%<\/td>\n<td>58.42%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/alkem\/alkem-laboratories-ltd-share-price-today\">Alkem Laboratories Ltd.<\/a><\/td>\n<td>-6.71%<\/td>\n<td>-11.49%<\/td>\n<td>-11.31%<\/td>\n<td>-9.95%<\/td>\n<td>30.24%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\">Sun Pharmaceutical Industries Ltd.<\/a><\/td>\n<td>-6.74%<\/td>\n<td>-10.91%<\/td>\n<td>4.46%<\/td>\n<td>3.22%<\/td>\n<td>110.67%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/ajantpharm\/ajanta-pharma-ltd-share-price-today\">Ajanta Pharma Ltd.<\/a><\/td>\n<td>-6.87%<\/td>\n<td>-4.9%<\/td>\n<td>18.61%<\/td>\n<td>35.41%<\/td>\n<td>128.88%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\">Zydus Lifesciences Ltd.<\/a><\/td>\n<td>-4.06%<\/td>\n<td>-3.05%<\/td>\n<td>18.94%<\/td>\n<td>11.13%<\/td>\n<td>111.33%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/gland\/gland-pharma-ltd-share-price-today\">Gland Pharma Ltd.<\/a><\/td>\n<td>2.71%<\/td>\n<td>22.8%<\/td>\n<td>68.27%<\/td>\n<td>56.89%<\/td>\n<td>-19.2%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/drreddy\/dr-reddy's-laboratories-ltd-share-price-today\">Dr. Reddy&#8217;s Laboratories Ltd.<\/a><\/td>\n<td>3.69%<\/td>\n<td>1.59%<\/td>\n<td>0.8%<\/td>\n<td>-3.08%<\/td>\n<td>29.38%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/glenmark\/glenmark-pharmaceuticals-ltd-share-price-today\">Glenmark Pharmaceuticals Ltd.<\/a><\/td>\n<td>-9.79%<\/td>\n<td>-1.31%<\/td>\n<td>-0.92%<\/td>\n<td>19.29%<\/td>\n<td>328.62%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi's-laboratories-ltd-share-price-today\">Divi&#8217;s Laboratories Ltd.<\/a><\/td>\n<td>-3.44%<\/td>\n<td>24.17%<\/td>\n<td>44.7%<\/td>\n<td>37.6%<\/td>\n<td>75.02%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/lauruslabs\/laurus-labs-ltd-share-price-today\">Laurus Labs Ltd.<\/a><\/td>\n<td>2.55%<\/td>\n<td>32.72%<\/td>\n<td>83.18%<\/td>\n<td>124.73%<\/td>\n<td>235.33%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\">Cipla Ltd.<\/a><\/td>\n<td>-4.47%<\/td>\n<td>-8.15%<\/td>\n<td>7.69%<\/td>\n<td>-19.22%<\/td>\n<td>46.12%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\">Torrent Pharmaceuticals Ltd.<\/a><\/td>\n<td>-8.28%<\/td>\n<td>-8.92%<\/td>\n<td>8.77%<\/td>\n<td>27.68%<\/td>\n<td>196.7%<\/td>\n<\/tr>\n<\/table>\n<p>Looking beyond one session, the constituent return profile shows a more mixed and nuanced sector picture. Laurus Labs stands out strongly with gains of 32.72% over three months, 83.18% over six months, and 124.73% over one year. Divi&#8217;s Laboratories and Gland Pharma have also delivered strong medium-term performance, even though both were under pressure today.<\/p>\n<p>On the weaker side, Biocon has struggled across multiple periods, including negative returns over three months, six months, and one year. Natco Pharma, despite being today\u2019s top gainer, remains negative over three months, six months, and one year. This contrast highlights an important market lesson: one-day strength does not always reverse a weaker medium-term trend, and one-day weakness does not necessarily cancel out a strong longer trend.<\/p>\n<p>For investors studying Nifty Pharma today, this longer-period return table shows that the sector is not moving in lockstep beneath the surface. Some constituents still have very strong trailing momentum, while others remain in corrective phases.<\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"What_Investors_Should_Watch_Next\"><\/span>What Investors Should Watch Next<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The next session should be watched through three simple lenses. First is breadth: if the number of advancing stocks improves meaningfully from today\u2019s 3 against 16 decliners, it could indicate that today\u2019s weakness was temporary. If breadth remains this poor, the bearish tone may continue.<\/p>\n<p>Second is the intraday structure of the index. Today\u2019s close near the low signaled weak end-of-day demand. Investors should watch whether Nifty Pharma can hold above its opening range in the next session or whether sellers again overwhelm early buying attempts.<\/p>\n<p>Third is stock-level follow-through in the most influential movers of the day. Natco Pharma, Dr. Reddy&#8217;s Laboratories, and Laurus Labs showed resilience. On the other side, JB Chemicals &amp; Pharmaceuticals, Aurobindo Pharma, Biocon, and Granules India saw sharper selling. The next move in these stocks can help reveal whether the sector is stabilizing or whether pressure is spreading further.<\/p>\n<p>Activity is also worth monitoring. Today\u2019s high volumes in stocks such as JB Chemicals &amp; Pharmaceuticals, Cipla, Mankind Pharma, Laurus Labs, and Dr. Reddy&#8217;s Laboratories suggest that investors were actively repositioning within pharma. Continued heavy participation in subsequent sessions could provide clues about whether the market is building a base or extending weakness.<\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Key_Takeaways\"><\/span>Key Takeaways<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Nifty Pharma closed at 25,615, down 166.65 points or 0.65%.<\/li>\n<li>The index opened at 25,769.3, hit 26,020.45, fell to 25,565.4, and closed near the day\u2019s low.<\/li>\n<li>Market breadth was weak: 3 advancers, 16 decliners, and 1 unchanged stock.<\/li>\n<li>Natco Pharma was the top gainer at 2.01%, followed by Dr. Reddy&#8217;s Laboratories and Laurus Labs.<\/li>\n<li>JB Chemicals &amp; Pharmaceuticals was the top loser at -3.87%, followed by Aurobindo Pharma and Biocon.<\/li>\n<li>Nifty Pharma underperformed Nifty Metal, was nearly in line with Nifty Bank, and outperformed several other sector indices such as IT, FMCG, Financial Services, and Mid Select.<\/li>\n<li>The session\u2019s structure was bearish because the index failed to hold early strength and ended close to the intraday low.<\/li>\n<\/ul>\n<section class=\"univest-login-cta\" style=\"margin:28px 0;padding:24px;border-radius:10px;background:#eef5ff;border:1px solid #cddff7;text-align:center\">\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Know_more_with_Univest\"><\/span>Know more with Univest<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Log in to Univest to explore market insights, track stocks, and get <strong>3 free trade ideas<\/strong> on <a href=\"https:\/\/univest.in\/share-market-today\">Share Market Today<\/a>.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\" style=\"display:inline-block;padding:11px 20px;border-radius:6px;background:#1f4e79;color:#fff !important;text-decoration:none;font-weight:700\">Know More &#8211; Log In<\/a><\/p>\n<\/section>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span>Frequently Asked Questions<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"1_How_did_Nifty_Pharma_close_today\"><\/span>1. How did Nifty Pharma close today?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Nifty Pharma closed at 25,615 on 19 October 2026, down 166.65 points or 0.65% from the previous close of 25,781.65. The index also finished near its intraday low, which reflected weak momentum into the closing hour.<\/p>\n<h3 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"2_Why_did_Nifty_Pharma_fall_today\"><\/span>2. Why did Nifty Pharma fall today?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Nifty Pharma fell mainly because selling was broad-based across the index. Sixteen of the 20 constituents ended lower, while only three gained. The index also reversed after touching an intraday high, showing that early strength could not be sustained.<\/p>\n<h3 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"3_Which_stock_gained_the_most_in_Nifty_Pharma_today\"><\/span>3. Which stock gained the most in Nifty Pharma today?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Natco Pharma was the top gainer in Nifty Pharma today. It rose 15.8 points, or 2.01%, to close at 800.85. It was one of only three stocks in the index to finish the session in positive territory.<\/p>\n<h3 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"4_Which_stock_fell_the_most_in_Nifty_Pharma_today\"><\/span>4. Which stock fell the most in Nifty Pharma today?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>JB Chemicals &amp; Pharmaceuticals was the top loser in Nifty Pharma today. It declined 97.1 points, or 3.87%, to close at 2,408.9. It also saw very high trading activity during the session.<\/p>\n<h3 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"5_How_was_the_market_breadth_of_Nifty_Pharma_today\"><\/span>5. How was the market breadth of Nifty Pharma today?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Nifty Pharma breadth was weak. The index had 3 advancing stocks, 16 declining stocks, and 1 unchanged stock. That means only 15% of constituents closed in the green, while 80% ended in the red.<\/p>\n<h3 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"6_What_does_the_advance-decline_ratio_of_019_mean_for_Nifty_Pharma\"><\/span>6. What does the advance-decline ratio of 0.19 mean for Nifty Pharma?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>An advance-decline ratio of 0.19 indicates that decliners heavily outnumbered advancers. In practical terms, there was roughly one advancing stock for every five-plus declining stocks, which signals broad weakness across the sector rather than isolated pressure.<\/p>\n<h3 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"7_How_did_Nifty_Pharma_compare_with_other_sector_indices_today\"><\/span>7. How did Nifty Pharma compare with other sector indices today?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Nifty Pharma fell 0.65%, so it outperformed weaker indices such as Nifty IT, Nifty Financial Services, Nifty FMCG, and Nifty Mid Select. It was close to Nifty Bank, slightly better than Nifty Auto, but weaker than Nifty Metal.<\/p>\n<h3 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"8_Which_Nifty_Pharma_stocks_were_most_actively_traded_today\"><\/span>8. Which Nifty Pharma stocks were most actively traded today?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Among the actively traded Nifty Pharma stocks were JB Chemicals &amp; Pharmaceuticals, Cipla, Mankind Pharma, Laurus Labs, Dr. Reddy&#8217;s Laboratories, and Sun Pharmaceutical Industries. Their volumes and turnover show that participation remained strong despite the sector\u2019s weak close.<\/p>\n<h3 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"9_What_does_Nifty_Pharma_track\"><\/span>9. What does Nifty Pharma track?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Nifty Pharma is a sector index that tracks listed pharmaceutical companies within the Indian equity market. It is used by investors to understand how the pharma space is performing as a group rather than judging the sector through one individual stock.<\/p>\n<h3 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"10_How_many_stocks_are_in_Nifty_Pharma_and_what_should_investors_watch_next\"><\/span>10. How many stocks are in Nifty Pharma, and what should investors watch next?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Nifty Pharma had 20 constituents in this review. Investors should watch whether breadth improves in the next session, whether the index can avoid another close near the day\u2019s low, and whether today\u2019s top gainers and losers show follow-through.<\/p>\n<section class=\"univest-disclaimer\">\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Disclaimer\"><\/span>Disclaimer<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This sector-index update is for informational and educational purposes only and is not personalized investment advice or a recommendation to buy, sell, or hold any security.<\/p>\n<\/section>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"Nifty Pharma Today: Close, Stocks, Breadth and Performance\",\"datePublished\":\"2026-10-19T10:30:00.220Z\",\"dateModified\":\"2026-10-19T10:30:00.220Z\",\"mainEntityOfPage\":\"https:\/\/univest.in\/blogs\/nifty-pharma-today-market-wrap-2026\/\",\"author\":{\"@type\":\"Organization\",\"name\":\"Univest\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"Univest\"},\"about\":\"Nifty Pharma sector index movement\",\"isAccessibleForFree\":true}<\/script><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"How did Nifty Pharma close today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Nifty Pharma closed at 25,615 on 19 October 2026, down 166.65 points or 0.65% from the previous close of 25,781.65. The index also finished near its intraday low, which reflected weak momentum into the closing hour.\"}},{\"@type\":\"Question\",\"name\":\"Why did Nifty Pharma fall today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Nifty Pharma fell mainly because selling was broad-based across the index. Sixteen of the 20 constituents ended lower, while only three gained. The index also reversed after touching an intraday high, showing that early strength could not be sustained.\"}},{\"@type\":\"Question\",\"name\":\"Which stock gained the most in Nifty Pharma today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Natco Pharma was the top gainer in Nifty Pharma today. It rose 15.8 points, or 2.01%, to close at 800.85. It was one of only three stocks in the index to finish the session in positive territory.\"}},{\"@type\":\"Question\",\"name\":\"Which stock fell the most in Nifty Pharma today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"JB Chemicals & Pharmaceuticals was the top loser in Nifty Pharma today. It declined 97.1 points, or 3.87%, to close at 2,408.9. It also saw very high trading activity during the session.\"}},{\"@type\":\"Question\",\"name\":\"How was the market breadth of Nifty Pharma today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Nifty Pharma breadth was weak. The index had 3 advancing stocks, 16 declining stocks, and 1 unchanged stock. That means only 15% of constituents closed in the green, while 80% ended in the red.\"}},{\"@type\":\"Question\",\"name\":\"What does the advance-decline ratio of 0.19 mean for Nifty Pharma?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"An advance-decline ratio of 0.19 indicates that decliners heavily outnumbered advancers. In practical terms, there was roughly one advancing stock for every five-plus declining stocks, which signals broad weakness across the sector rather than isolated pressure.\"}},{\"@type\":\"Question\",\"name\":\"How did Nifty Pharma compare with other sector indices today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Nifty Pharma fell 0.65%, so it outperformed weaker indices such as Nifty IT, Nifty Financial Services, Nifty FMCG, and Nifty Mid Select. It was close to Nifty Bank, slightly better than Nifty Auto, but weaker than Nifty Metal.\"}},{\"@type\":\"Question\",\"name\":\"Which Nifty Pharma stocks were most actively traded today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Among the actively traded Nifty Pharma stocks were JB Chemicals & Pharmaceuticals, Cipla, Mankind Pharma, Laurus Labs, Dr. Reddy's Laboratories, and Sun Pharmaceutical Industries. Their volumes and turnover show that participation remained strong despite the sector\u2019s weak close.\"}},{\"@type\":\"Question\",\"name\":\"What does Nifty Pharma track?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Nifty Pharma is a sector index that tracks listed pharmaceutical companies within the Indian equity market. It is used by investors to understand how the pharma space is performing as a group rather than judging the sector through one individual stock.\"}},{\"@type\":\"Question\",\"name\":\"How many stocks are in Nifty Pharma, and what should investors watch next?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Nifty Pharma had 20 constituents in this review. Investors should watch whether breadth improves in the next session, whether the index can avoid another close near the day\u2019s low, and whether today\u2019s top gainers and losers show follow-through.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nifty Pharma today closed at 25,615, down 0.65%, with weak breadth and only three advancing stocks. Here is a full post-close analysis of the index, top gainers, top losers, constituent performance, market breadth, relative sector performance, and what investors should watch next.<\/p>\n","protected":false},"author":29,"featured_media":317412,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-238772","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["317412"],"rank_math_title":["Nifty Pharma Today: Close, Stocks &amp; Performance"],"rank_math_description":["Nifty Pharma today closed at 25,615, down 0.65%. See top gainers, losers, breadth, stock performance, sector comparison and key takeaways."],"rank_math_focus_keyword":["nifty pharma today"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/nifty-pharma-today-close-stocks-breadth-and-performance.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/238772","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=238772"}],"version-history":[{"count":11,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/238772\/revisions"}],"predecessor-version":[{"id":317413,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/238772\/revisions\/317413"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/317412"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=238772"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=238772"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=238772"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}